skint, page-3

Thanks for that conquest, but I am only in this stock to make money. I can wait a little longer, its not my only biotech investment. A more interesting question would be why it has attracted heavyweights in the field like Papadimitrou, with hundreds of published scientific papers and an order of Australia, and a proffessional like Dr Howie. He is from Pfizer of New York. Has been in charge of new drug developement of a company with a research budget of $billions. Why would they work for a tiny company like Solbec? What can they see? With phase 2 trials starting, the company saying they will release results as they can, I think it is a shame you have sold your shares at this point of time. Good luck.